CAPR Deadline Alert: Capricor Therapeutics Investors are Reminded of the Ongoing Securities Fraud Class Action to Recover Losses and Imminent September 28 Case Deadline
Bleichmar Fonti & Auld LLP issued a deadline alert reminding Capricor Therapeutics investors of the September 28, 2026 lead-plaintiff deadline in a securities fraud class action pending in the U.S. District Court for the Southern District of California, captioned Nkamga v. Capricor Therapeutics, Inc. et al., No.
Key figures
- Adcomm vote
- non-binding 9-3 against efficacy
- Close after drop
- 7
- Close before drop
- 19.7
- Stock drop pct jul27
- 64.5%
- Stock drop pct jul30
- 36%
- Stock drop usd jul27
- $12.70
- Stock drop usd jul30
- $2.38
- Close after second drop
- 4.19
- Lead plaintiff deadline
- September 28, 2026
- Close before second drop
- 6.57
- Complete response letter
- July 2025
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.